Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
borracare
- Development stage
- Unknown
- Lead developer
- Amato Pharmaceutical Products
- Administration
- Oral
01
Overview
Borracare is a line of dietary supplements developed and marketed by Amato Pharmaceutical Products, a Japanese company specializing in anal and digestive health. The Borracare series is designed to support bowel regularity and maintain a healthy intestinal environment, serving as an internal health complement to the company's flagship Borraginol hemorrhoid treatment brand. These supplements typically contain ingredients such as lactic acid bacteria (probiotics) and dietary fiber, which are intended to prevent constipation and promote overall gastrointestinal wellness, thereby reducing the risk factors associated with hemorrhoids.
- Brand names
- BORRACARE
- Other names
- BORRACARE supplements
Beyond the preview
Go deeper on borracare.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on borracare.